Avidity biosciences to participate in upcoming investor conferences

San diego , sept. 25, 2023 /prnewswire/ -- avidity biosciences, inc. (nasdaq: rna), a biopharmaceutical company committed to delivering a new class of rna therapeutics called antibody oligonucleotide conjugates (aocs™), today announced that avidity management will be participating at the following upcoming conferences: chardan 7th annual genetic medicines conference on october 3 at 6:00 a.m.
RNA Ratings Summary
RNA Quant Ranking